Nimbus CEO @jebkeiper joined @Ldtimmerman’s Long Run podcast to share personal insights on the Nimbus story from our computational beginnings 14 years ago, through the Takeda acquisition of our allosteric TYK2 inhibitor, and what our next chapter holds.